Circulating microRNAs as potential new biomarkers for prostate cancer
Top Cited Papers
Open Access
- 30 April 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 108 (10), 1925-1930
- https://doi.org/10.1038/bjc.2013.192
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Dysregulation of circulating microRNAs and prediction of aggressive prostate cancerThe Prostate, 2012
- Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of diseaseInternational Journal of Cancer, 2011
- Development of a miRNA-based diagnostic assay for pancreatic ductal adenocarcinomaExpert Review of Molecular Diagnostics, 2011
- Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancerTumor Biology, 2011
- Serum miRNA‐21: Elevated levels in patients with metastatic hormone‐refractory prostate cancer and potential predictive factor for the efficacy of docetaxel‐based chemotherapyThe Prostate, 2010
- Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)Methods, 2010
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate CancerClinical Cancer Research, 2008
- THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CANCER OF THE PROSTATE RISK ASSESSMENT SCORE: A STRAIGHTFORWARD AND RELIABLE PREOPERATIVE PREDICTOR OF DISEASE RECURRENCE AFTER RADICAL PROSTATECTOMYJournal of Urology, 2005
- VALIDATION OF THE KATTAN PREOPERATIVE NOMOGRAM FOR PROSTATE CANCER RECURRENCE USING A COMMUNITY BASED COHORT: RESULTS FROM CANCER OF THE PROSTATE STRATEGIC UROLOGICAL RESEARCH ENDEAVOR (CAPSURE)Journal of Urology, 2004
- Dicer is essential for mouse developmentNature Genetics, 2003